Skip to main content

Study Design in DIGE-Based Biomarker Discovery

  • Protocol
  • First Online:
Difference Gel Electrophoresis (DIGE)

Part of the book series: Methods in Molecular Biology ((MIMB,volume 854))

Abstract

The DIGE technology allows the detection of small differences in the expression level of abundant proteins. Many diseases are associated with quantitative deviations of proteins which might represent useful biomarkers for diagnosis or prognosis. DIGE is therefore a highly convenient method for the characterization of disease-related expression changes. This chapter focuses on the study design in DIGE-based biomarker discovery. It introduces the statistical implications of testing thousands of proteins in parallel and discusses the solutions proposed by the literature. The outline provided in the method section tries to guide the researcher through the different statistical considerations, which have to be taken into account in biomarker detection. Special emphasis is given to the use of sample sizes of sufficient statistical power and to the statistical evaluation of the results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bossuyt, P.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49, 1–6 (2003).

    Google Scholar 

  2. McShane, L.M., et al. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23, 9067–9072 (2005).

    Article  PubMed  Google Scholar 

  3. Mischak, H., et al. Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2, 46ps42 (2010).

    Google Scholar 

  4. Dudoit, S., Shaffer, J. & Boldrick, J. Multiple hypothesis testing in microarray experiments. Statistical Science 18, 71–103 (2003).

    Article  Google Scholar 

  5. Shaffer, J.P. Multiple Hypothesis Testing. Annual Review of Psychology 46, 561–584 (1995).

    Article  Google Scholar 

  6. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate—A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57, 289–300 (1995).

    Google Scholar 

  7. Benjamini, Y. & Yekutieli, D. The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics 29, 1165–1188 (2001).

    Article  Google Scholar 

  8. Storey, J.D. A direct approach to false discovery rate. Journal of the Royal Statistical Society, Series B 64, 479–498 (2002).

    Article  Google Scholar 

  9. Storey, J.D., Taylor, J.E. & Siegmund, D. Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. Journal of the Royal Statistical Society, Series B 66, 187–205 (2004).

    Article  Google Scholar 

  10. Pawitan Y., Michiels, S., Koscielny, S., Gusnanto, A. & Ploner, A. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 21, 3017–3024 (2005).

    Article  PubMed  CAS  Google Scholar 

  11. Jung, S.H. Sample size for FDR-control in microarray data analysis. Bioinformatics 21, 3079–3104 (2005).

    Article  Google Scholar 

  12. Petrak, J., et al. Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 8, 1744–1749 (2008).

    Google Scholar 

  13. Unlu, M., Morgan, M.E. & Minden, J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071–2077 (1997).

    Article  PubMed  CAS  Google Scholar 

  14. Directorate-General-Health-and-Consumer-Protection. Guidance for generating and reporting methods of analysis in support of pre-registration data requirements. Vol. Annex II (part A, Section 4) and Annex III (part A, Section 5) of Directive 91/414. (ed. EUROPEAN-COMMISSION) (Brussels, BE, 2000).

    Google Scholar 

  15. Biopharmaceutics-Coordinating-Committee. Guidance for Industry: Bioanalytical Method Validation. (ed. U.S. Department of Health and Human Services, F.a.D.A., Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM)) (Rockville MD 2057, USA, 2001).

    Google Scholar 

Download references

Acknowledgments

We thank Sonja Zehetmayer for helpful comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rudolf Oehler .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Graf, A., Oehler, R. (2012). Study Design in DIGE-Based Biomarker Discovery. In: Cramer, R., Westermeier, R. (eds) Difference Gel Electrophoresis (DIGE). Methods in Molecular Biology, vol 854. Humana Press. https://doi.org/10.1007/978-1-61779-573-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-573-2_14

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-572-5

  • Online ISBN: 978-1-61779-573-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics